0001140361-21-008342.txt : 20210312 0001140361-21-008342.hdr.sgml : 20210312 20210312163555 ACCESSION NUMBER: 0001140361-21-008342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wrighton-Smith Peter CENTRAL INDEX KEY: 0001592286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 21737970 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 form4.xml FORM 4 X0306 4 2021-03-08 true 0001586049 Oxford Immunotec Global PLC OXFD 0001592286 Wrighton-Smith Peter C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM true true Chief Executive Officer Ordinary Shares 2021-03-08 4 D 0 400225 22 D 0 D Stock Option (Right to Buy) 14.12 2021-03-08 4 D 0 41931 7.88 D 2025-06-19 Ordinary Shares 41931 0 D Stock Option (Right to Buy) 13.5 2021-03-08 4 D 0 105255 8.5 D 2027-02-24 Ordinary Shares 105255 0 D Stock Option (Right to Buy) 13.24 2021-03-08 4 D 0 103330 8.76 D 2028-03-15 Ordinary Shares 103330 0 D Stock Option (Right to Buy) 16.42 2021-03-08 4 D 0 67959 5.58 D 2029-04-01 Ordinary Shares 67959 0 D Stock Option (Right to Buy) 12.19 2021-03-08 4 D 0 62087 9.81 D 2030-03-11 Ordinary Shares 62087 0 D Stock Option (Right to Buy) 10.21 2021-03-08 4 D 0 128959 11.79 D 2026-03-04 Ordinary Shares 128959 0 D Stock Option (Right to Buy) 14.57 2021-03-08 4 D 0 51403 7.43 D 2025-01-16 Ordinary Shares 51403 0 D Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited (the "Bidco") of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme"). In connection with the Scheme, all stock options were transferred to Bidco in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. Represents the payment per ordinary share received in exchange for the transfer of each option of $22.00, less the applicable exercise price. /s/ Matthew T E McLaughlin, as Attorney-in-Fact for Peter Wrighton-Smith 2021-03-12